Enlist- Evaluating Nulojix Long-Term Safety In Transplant Trademark Details

Enlist- Evaluating Nulojix Long-Term Safety in Transplant was registered on Tuesday, December 16, 2014 and is currently owned by Bristol-Myers Squibb Company under the registration number 4656507 . This mark is alive with a status of Registered. The last case file activity for this mark occured 8 years ago on Tuesday, December 16, 2014, according to the United State Patent & Trademark Office
Word Mark Enlist- Evaluating Nulojix Long-Term Safety in Transplant
Status Alive Registered 700 — Registered

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 85283401
Registration Number 4656507
Status Date Tuesday, December 16, 2014
Filing Date Tuesday, December 16, 2014
Registration Date Tuesday, December 16, 2014
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT. - MAILSTOP D33-05
P.O. BOX 4000
PRINCETON NJ 08648-4000

Case File Statements

Disclaimer with Predetermined Text "Evaluating" or "Long-Term Safety in Transplant"
Goods & Services Providing an online computer database featuring a registry of medical information regarding safety in organ transplants

Classifications

International Class Codes
044 — Class 44 includes mainly medical care, hygienic and beauty care given by persons or establishments to human beings and animals; it also includes services relating to the fields of agriculture, horticulture and forestry.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Wednesday, November 2, 2011
First Use Anywhere Thursday, June 16, 2011
First Use In Commerce Thursday, June 16, 2011
Primary Code 044

You must be signed in to print.

Once signed in, look for the PDF button.